Correlation Between Inhibrx and Lantern Pharma
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Lantern Pharma, you can compare the effects of market volatilities on Inhibrx and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Lantern Pharma.
Diversification Opportunities for Inhibrx and Lantern Pharma
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Inhibrx and Lantern is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of Inhibrx i.e., Inhibrx and Lantern Pharma go up and down completely randomly.
Pair Corralation between Inhibrx and Lantern Pharma
Given the investment horizon of 90 days Inhibrx is expected to generate 0.73 times more return on investment than Lantern Pharma. However, Inhibrx is 1.38 times less risky than Lantern Pharma. It trades about -0.01 of its potential returns per unit of risk. Lantern Pharma is currently generating about -0.03 per unit of risk. If you would invest 1,595 in Inhibrx on September 2, 2024 and sell it today you would lose (69.00) from holding Inhibrx or give up 4.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. Lantern Pharma
Performance |
Timeline |
Inhibrx |
Lantern Pharma |
Inhibrx and Lantern Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Lantern Pharma
The main advantage of trading using opposite Inhibrx and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Lantern Pharma vs. Tff Pharmaceuticals | Lantern Pharma vs. Eliem Therapeutics | Lantern Pharma vs. Inhibrx | Lantern Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |